close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar43Point61
Implied share price

Buy Undervalued by 5.7%

5% margin of safety What's this?

EV / EBITDA
Use Average
MYL
Mylan Inc.
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
9.92 9.5 12.21 4.95 17.08 5.09
All amounts in millions
from last financial year
         
Implied Share Price $43.61 $141.23 $169.44 $56.52 $80.16
Market Cap 22,070 130,102 107,921 100,042 98,744
Net Debt 6,137 47 7,450 -3,369 7,330
Enterprise Value (EV) 28,208 130,149 115,371 96,673 56,725
Revenue 9,429 21,662 32,639 13,418 34,861
EBITDA 2,969 10,657 23,287 5,661 11,136
Percent 31.5 % 49.2 % 71.3 % 42.2 % 31.9 %
EBIT 1,937 8,530 22,189 5,069 7,186
Percent 20.5 % 39.4 % 68.0 % 37.8 % 20.6 %
Balance Sheet          
Total Assets 22,267 71,449 51,716 21,787 102,321
Total Liabilities 12,503 43,366 33,182 6,116 44,272
Shareholders Equity 9,764 28,083 18,534 15,671 58,049.0

Comments

No comments yet. Login to comment.